{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:44:22Z","timestamp":1770507862832,"version":"3.49.0"},"reference-count":30,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.3892\/mco.2014.320","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T12:52:11Z","timestamp":1403182331000},"page":"719-724","source":"Crossref","is-referenced-by-count":14,"title":["Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II\/III N1, 2 esophageal cancer"],"prefix":"10.3892","volume":"2","author":[{"given":"TADASUKE","family":"HASHIGUCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOTOMI","family":"NASU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"HASHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TETSUJI","family":"KUNIYASU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROHUMI","family":"INOUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NORITAKA","family":"SAKAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUTOMO","family":"OUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAYUKI","family":"AMANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUYUMI","family":"ISAYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NATSUMI","family":"TOMITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIMI","family":"IWANUMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIKO","family":"TSURUMARU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIAKI","family":"KAJIYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"key20180107150830_b1-mco-02-05-0719","first-page":"343","article-title":"Esophagectomy with lymph node dissection through right thoracotomy","volume":"103","author":"Kajiyama","year":"2002","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"key20180107150830_b2-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000658-199409000-00012","article-title":"Radical lymph node dissection for cancer of the thoracic esophagus","volume":"220","author":"Akiyama","year":"1994","journal-title":"Ann Surg"},{"key":"key20180107150830_b3-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3919\/jjsa.68.795","article-title":"Indication and limitation of 3-field lymph node dissection surgery for esophageal cancer from survival analysis","volume":"68","author":"Kajiyama","year":"2007","journal-title":"J Jpn Surg Assoc"},{"key":"key20180107150830_b4-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"542","DOI":"10.14789\/pjmj.53.542","article-title":"Current surgical treatment for esophageal cancer: Indication and limitation of 3-field lymph node dissection surgery based on survival analysis","volume":"53","author":"Kajiyama","year":"2007","journal-title":"Juntendo Med J"},{"key":"key20180107150830_b5-mco-02-05-0719","first-page":"23","article-title":"Guide line for the clinical and pathologic studies on carcinoma of the esophagus. 9th edition","volume":"8","year":"1999","journal-title":"Japan Esophageal Society"},{"key":"key20180107150830_b6-mco-02-05-0719","article-title":"TNM Classification of Malignant Tumours","volume-title":"International Union Against Cancer (UICC)","author":"Sobin","year":"2009","edition":"7th edition"},{"key":"key20180107150830_b7-mco-02-05-0719","volume-title":"Japanese translation of common terminology criteria for adverse events (CTCAE) version 4.0","year":"2009"},{"key":"key20180107150830_b8-mco-02-05-0719","first-page":"151","article-title":"Preservation of right and left bronchial arteries","volume":"30","author":"Kajiyama","year":"2007","journal-title":"Gastroentrological Surg"},{"key":"key20180107150830_b9-mco-02-05-0719","first-page":"357","article-title":"Treatment of esophageal cancer: open vs. thoracoscopic surgery","volume":"106","author":"Kajiyama","year":"2005","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"key20180107150830_b10-mco-02-05-0719","first-page":"1","article-title":"Lymph node dissection along the recurrent laryngeal nerve and preservation of bronchial artery in esophageal cancer surgery","volume":"34","author":"Kajiyama","year":"2011","journal-title":"Gastroentrological Surg"},{"key":"key20180107150830_b11-mco-02-05-0719","article-title":"Surgical and anatomical problems of the vagus nerve (recurrent laryngeal nerve) in patients with cancer of the thoracic esophagus: View of open surgery","author":"Tsurumaru","year":"2005"},{"key":"key20180107150830_b12-mco-02-05-0719","first-page":"1079","article-title":"Progress and perspective of trans-thoracic esophageal cancer surgery","volume":"35","author":"Kajiyama","year":"2012","journal-title":"Gastroentrological Surg"},{"key":"key20180107150830_b13-mco-02-05-0719","first-page":"1225","article-title":"Controversies in esophageal cancer surgery","volume":"30","author":"Kajiyama","year":"2003","journal-title":"Jpn J Cancer Chemother"},{"key":"key20180107150830_b14-mco-02-05-0719","first-page":"69","article-title":"New strategy for esophageal cancer","volume":"84","author":"Matsubara","year":"2008","journal-title":"Chiba Igaku Zasshi"},{"key":"key20180107150830_b15-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1200\/JCO.2003.12.095","article-title":"Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology group study - JCOG 9204","volume":"21","author":"Ando","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107150830_b16-mco-02-05-0719","volume-title":"Guide line on diagnosis and treatment for esophageal cancer","year":"2007","edition":"2th edition"},{"key":"key20180107150830_b17-mco-02-05-0719","first-page":"880","article-title":"Prolonged chemothrerapy for localized squamous carcinoma of the oesophagus","volume-title":"Eur J Cancer","author":"Ajani","year":"1992"},{"key":"key20180107150830_b18-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0003-4975(98)90004-2","article-title":"Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus","volume":"45","author":"Hilgenberg","year":"1988","journal-title":"Ann Thorac Surg"},{"key":"key20180107150830_b19-mco-02-05-0719","first-page":"159","article-title":"Chemothrapy of esophageal cancer","volume":"11","author":"Kelsen","year":"1984","journal-title":"Semin Oncol"},{"key":"key20180107150830_b20-mco-02-05-0719","first-page":"172","article-title":"Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus:a Japanese Esophageal Oncology Group Trial","volume":"22","author":"Iizuka","year":"1992","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107150830_b21-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/bjc.1996.469","article-title":"Cisplatin and etoposide in oesophageal cancer: a phase II study","volume":"74","author":"Kok","year":"1996","journal-title":"Br J Cancer"},{"key":"key20180107150830_b22-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","article-title":"Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer","volume":"17","author":"Ilson","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180107150830_b23-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1200\/JCO.1998.16.5.1826","article-title":"Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus","volume":"16","author":"Ilson","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20180107150830_b24-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/annonc\/mdh063","article-title":"Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophaeal cancer","volume":"15","author":"Kroep","year":"2004","journal-title":"Ann Oncol"},{"key":"key20180107150830_b25-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/sj.bjc.6602842","article-title":"Phase II study of gemcitabine and cisplatin in locally advanced\/metastatic oesophageal cancer","volume":"93","author":"Millar","year":"2005","journal-title":"Br J Cancer"},{"key":"key20180107150830_b26-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/annonc\/mdi249","article-title":"Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus","volume":"16","author":"Mauer","year":"2005","journal-title":"Ann Oncol"},{"key":"key20180107150830_b27-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.bjc.6603750","article-title":"First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study","volume":"96","author":"van Meerten","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180107150830_b28-mco-02-05-0719","first-page":"1117","article-title":"Current realities and problems of chemotherapy for esophageal cancer","volume":"35","author":"Tsuda","year":"2012","journal-title":"Gastroentrological Surg"},{"key":"key20180107150830_b29-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107150830_b30-mco-02-05-0719","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.320\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T18:31:40Z","timestamp":1565548300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,6,19]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.3892\/mco.2014.320"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.320","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}